✦ LIBER ✦

Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia

✍ Scribed by Jones, Dan; Kamel-Reid, Suzanne; Bahler, David; Dong, Henry; Elenitoba-Johnson, Kojo; Press, Richard; Quigley, Neil; Rothberg, Paul; Sabath, Dan; Viswanatha, David; Weck, Karen; Zehnder, James

Book ID: 120350867
Publisher: American Society for Investigative Pathology
Year: 2009
Tongue: English
Weight: 243 KB
Volume: 11
Category: Article
ISSN: 1525-1578
DOI: 10.2353/jmoldx.2009.080095

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The BCR/ABL-extra signal fluorescence in

The BCR/ABL-extra signal fluorescence in situ hybridization system reliably detects deletions upstream of the ABL locus: implications for reporting of results and followup of chronic myelogenous leukemia patients

✍ Christel Müller; Evelin Hennig; Christina Franke; Rainer Krahl; Sabine Leiblein; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Drug resistance and BCR-ABL kinase domai

Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the fr

✍ Soverini, Simona; De Benedittis, Caterina; Papayannidis, Cristina; Paolini, Stef 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB